Solicitation for the Nomination of Candidates To Serve as Voting Members and Representatives of the National Vaccine Advisory Committee, 70776-70777 [E6-20636]
Download as PDF
70776
Federal Register / Vol. 71, No. 234 / Wednesday, December 6, 2006 / Notices
Use: The purpose of the data
collection and evaluation is to
determine the efficacy of the National
Abstinence Media Campaign and its
messages upon parents, specifically to
encourage and help parents talk to their
pre-teens and teens about waiting to
have sex.
The following outcomes will be
examined: perceived risks from teen
sexual activity, perceived susceptibility,
attitude towards teen sexual activity,
self-efficacy to talk to their child,
outcome efficacy, perceived value of
delayed sexual activity, and parentchild communication about sex.
Frequency: Reporting on Occasion.
Affected Public: Individuals or
Households.
Annual Number of Respondents:
947.5.
Total Annual Responses: 3,493.5.
Average Burden Per Response: 30
mins.
Total Annual Hours: 1,746.75.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, e-mail your request,
including your address, phone number,
OMB number, and OS document
identifier, to
Sherette.funncoleman@hhs.gov, or call
the Reports Clearance Office on (202)
690–6162. Written comments and
recommendations for the proposed
information collections must be
received within 30 days of this notice
directly to the Desk Officer at the
address below:
OMB Desk Officer: John Kraemer,
OMB Human Resources and Housing
Branch, Attention: (OMB #0990–New),
New Executive Office Building, Room
10235, Washington, DC 20503.
Dated: November 28, 2006.
Alice Bettencourt,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. E6–20583 Filed 12–5–06; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PWALKER on PRODPC60 with NOTICES
[Document Identifier: OS–0990–0000; 30day notice]
Office of the Secretary; Agency
Information Collection Activities:
Proposed Collection; Comment
Request
Agency: Office of the Secretary, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Office of the Secretary (OS), Department
VerDate Aug<31>2005
16:03 Dec 05, 2006
Jkt 211001
of Health and Human Services, is
publishing the following summary of a
proposed collection for public
comment. Interested persons are invited
to send comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Type of Information Collection
Request: New Collection.
Title of Information Collection: The
Heart Truth Professional Materials
Program Evaluation.
Form/OMB No.: OS–0990–0000.
Use: The Heart Truth Campaign was
launched by the National Heart, Lung,
and Blood Institute (NHLBI) in
September 2002 to increase women’s
awareness of heart disease. The Heart
Truth joins together leaders in women’s
health—along with corporate and media
partners—to create a national movement
aimed at delivering an urgent wake-up
call to women about heart disease.
As part of The Heart Truth campaign,
Office on Women’s Health funded
programs to develop and disseminate
educational materials for health care
professionals. This information
collection ascertains whether health
care professionals exposed to the
program materials have incorporated
what they learned into their
professional practice.
Frequency: One time.
Affected Public: Individuals or
Households.
Annual Number of Respondents: 400.
Total Annual Responses: 400.
Average Burden Per Response: 0.1
hours.
Total Annual Hours: 40 hours.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, e-mail your request,
including your address, phone number,
OMB number, and OS document
identifier, to
Sherette.funncoleman@hhs.gov, or call
the Reports Clearance Office on (202)
690–6162. Written comments and
recommendations for the proposed
information collections must be
received within 30 days of this notice
directly to the Desk Officer at the
address below:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
OMB Desk Officer: John Kraemer,
OMB Human Resources and Housing
Branch, Attention: (OMB #0990–0000),
New Executive Office Building, Room
10235, Washington, DC 20503.
Dated: November 28, 2006.
Alice Bettencourt,
Office of the Secretary, Paperwork Reduction
Act Reports Clearance Officer.
[FR Doc. E6–20585 Filed 12–5–06; 8:45 am]
BILLING CODE 4150–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation for the Nomination of
Candidates To Serve as Voting
Members and Representatives of the
National Vaccine Advisory Committee
Office of Public Health and
Science, Office of the Secretary, HHS.
ACTION: Notice.
AGENCY:
Authority: 42 U.S.C. 300aa–5, Section 2105
of the Public Health Service (PHS) Act, as
amended. The Committee is governed by the
provisions of Public Law 92–463, as
amended (5 U.S.C. Appendix 2), which sets
forth standards for the formation and use of
advisory committees.
SUMMARY: The National Vaccine
Program Office (NVPO), a program
office within the Office of Public Health
and Science, DHHS, is soliciting
nominations of qualified candidates to
be considered for appointment as
members and representatives to the
National Vaccine Advisory Committee
(NVAC). The activities of this
Committee are governed by the Federal
Advisory Committee Act (FACA).
Consistent with the National Vaccine
Plan, the Committee advises and makes
recommendations to the Assistant
Secretary for Health in his/her capacity
as the Director of the National Vaccine
Program, on matters related to the
Program’s responsibilities.
Specifically, the Committee studies
and recommends ways to encourage the
availability of an adequate supply of
safe and effective vaccination products
in the United States; recommends
research priorities and other measures
to enhance the safety and efficacy of
vaccines. The Committee also advises
the Assistant Secretary for Health in the
implementation of Sections 2102 and
2103 of the PHS Act; and identifies
annually the most important areas of
government and non-government
cooperation that should be considered
in implementing Sections 2102 and
2103 of the PHS Act.
DATES: Nominations for membership on
the Committee must be received no later
E:\FR\FM\06DEN1.SGM
06DEN1
PWALKER on PRODPC60 with NOTICES
Federal Register / Vol. 71, No. 234 / Wednesday, December 6, 2006 / Notices
than 5 p.m. EST on January 19, 2007, at
the address below.
ADDRESSES: Bruce G. Gellin, M.D.,
M.P.H., Executive Secretary, National
Vaccine Advisory Committee, Office of
Public Health and Science, Department
of Health and Human Services, 200
Independence Avenue, SW., Room 443–
H, Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms.
Emma English, Program Analyst,
National Vaccine Program Office,
Department of Health and Human
Services, 200 Independence Avenue,
SW., Room 443–H, Washington, DC
20201; (202) 690–5566;
nvac@osophs.dhhs.gov.
A copy of the Committee charter and
list of the current membership can be
obtained by contacting Ms. English or
by accessing the NVAC Web site at:
https://www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION: Committee
Function: Qualifications and
Information Required: As part of an
ongoing effort to enhance deliberations
and discussions with the public on
vaccine and immunization policy,
nominations are being sought for
interested individuals to serve on the
Committee. Individuals selected for
appointment to the Committee will
serve as voting members. Voting
members shall be selected from
individuals who are engaged in vaccine
research or the manufacture of vaccines,
or who are physicians, members of
parent organizations concerned with
immunizations, representatives of State
or local health agencies, or public health
organizations. Individuals selected for
appointment to the Committee can be
invited to serve terms with periods of
up to four years.
Nominations should be typewritten.
The following information should be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e., specific
attributes which qualify the nominee for
service in this capacity), and a statement
that the nominee is willing to serve as
a member of the Committee; (2) the
nominator’s name, address, and daytime
telephone number, and the home and/
or work address, telephone number, and
e-mail address of the individual being
nominated; and (3) a current copy of the
nominee’s curriculum vitae.
Applications cannot be submitted by
facsimile. The names of Federal
employees should not be submitted for
consideration of appointment to this
Committee.
VerDate Aug<31>2005
16:03 Dec 05, 2006
Jkt 211001
The Department makes every effort to
ensure that the membership of HHS
Federal advisory committees is fairly
balanced in terms of points of view
represented and the committee’s
function. Every effort is made to ensure
that a broad representation of
geographic areas, gender, ethnic and
minority groups, and the disabled are
given consideration for membership on
HHS Federal advisory committees.
Appointment to this committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status.
Dated: November 30, 2006.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. E6–20636 Filed 12–5–06; 8:45 am]
70777
panel discussion on the American
Health Information Management
Association’s State Steering Committee
Recommendations; and an update on
the National Health Information
Network (NHIN). The instructions to
participate remotely (Web cast and/or
telephone) can be found at https://
www.hhs.gov/healthit/m20061212.html.
If you have any questions concerning
the remote instructions or meeting
format, please call (866) 505–3500.
Dated: November 30, 2006.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 06–9549 Filed 12–5–06; 8:45 am]
BILLING CODE 4150–24–M
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the National Coordinator for
Health Information Technology;
American Health Information
Community Meeting
Amendment of meeting
announcement, dated November 28,
2006.
ACTION:
SUMMARY: This notice amends the
announcement of the tenth meeting of
the American Health Information
Community in accordance with the
Federal Advisory Committee Act (Pub.
L. 92–463, 5 U.S.C., App.) The
American Health Information
Community will advise the Secretary
and recommend specific actions to
achieve a common interoperability
framework for health information
technology (IT).
DATES: December 12, 2006, from 8:30 to
11:30 a.m.
Meeting Format: This meeting was
originally scheduled to be held in the
Hubert H. Humphrey Building (200
Independence Avenue, SW.,
Washington, DC 20201), Conference
Room 800. However, the meeting format
has been changed to provide remote
participation only (Web cast and/or
telephone) for the Community members,
HHS staff, invited presenters, and
general public. A time period will be
allotted before the conclusion of the
meeting for the general public to deliver
brief (3 minutes or less) oral public
comment.
The
agenda includes an update on the
Personalized Healthcare Workgroup; a
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) allow the proposed
information collection project: ‘‘Pilot
Study of Proposed Medical Office
Surveys on Patient Safety.’’ In
accordance with the Paperwork
Reduction Act of 1995, Public Law 104–
13 (44 U.S.C. 3506(c)(2)(A)), AHRQ
invites the public to comment on this
proposed information collection.
Comments on this notice must be
received by February 5, 2007.
DATES:
Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, 540
Gaither Road, Room 5036, Rockville,
MD 20850. Copies of the proposed
collection plans, data collection
instruments, and specific details on the
estimated burden can be obtained from
AHRQ’s Reports Clearance Officer.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ, Reports
Clearance Officer, (301) 427–1477.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\06DEN1.SGM
06DEN1
Agencies
[Federal Register Volume 71, Number 234 (Wednesday, December 6, 2006)]
[Notices]
[Pages 70776-70777]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20636]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation for the Nomination of Candidates To Serve as Voting
Members and Representatives of the National Vaccine Advisory Committee
AGENCY: Office of Public Health and Science, Office of the Secretary,
HHS.
ACTION: Notice.
-----------------------------------------------------------------------
Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health
Service (PHS) Act, as amended. The Committee is governed by the
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2),
which sets forth standards for the formation and use of advisory
committees.
SUMMARY: The National Vaccine Program Office (NVPO), a program office
within the Office of Public Health and Science, DHHS, is soliciting
nominations of qualified candidates to be considered for appointment as
members and representatives to the National Vaccine Advisory Committee
(NVAC). The activities of this Committee are governed by the Federal
Advisory Committee Act (FACA).
Consistent with the National Vaccine Plan, the Committee advises
and makes recommendations to the Assistant Secretary for Health in his/
her capacity as the Director of the National Vaccine Program, on
matters related to the Program's responsibilities.
Specifically, the Committee studies and recommends ways to
encourage the availability of an adequate supply of safe and effective
vaccination products in the United States; recommends research
priorities and other measures to enhance the safety and efficacy of
vaccines. The Committee also advises the Assistant Secretary for Health
in the implementation of Sections 2102 and 2103 of the PHS Act; and
identifies annually the most important areas of government and non-
government cooperation that should be considered in implementing
Sections 2102 and 2103 of the PHS Act.
DATES: Nominations for membership on the Committee must be received no
later
[[Page 70777]]
than 5 p.m. EST on January 19, 2007, at the address below.
ADDRESSES: Bruce G. Gellin, M.D., M.P.H., Executive Secretary, National
Vaccine Advisory Committee, Office of Public Health and Science,
Department of Health and Human Services, 200 Independence Avenue, SW.,
Room 443-H, Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst,
National Vaccine Program Office, Department of Health and Human
Services, 200 Independence Avenue, SW., Room 443-H, Washington, DC
20201; (202) 690-5566; nvac@osophs.dhhs.gov.
A copy of the Committee charter and list of the current membership
can be obtained by contacting Ms. English or by accessing the NVAC Web
site at: https://www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION: Committee Function: Qualifications and
Information Required: As part of an ongoing effort to enhance
deliberations and discussions with the public on vaccine and
immunization policy, nominations are being sought for interested
individuals to serve on the Committee. Individuals selected for
appointment to the Committee will serve as voting members. Voting
members shall be selected from individuals who are engaged in vaccine
research or the manufacture of vaccines, or who are physicians, members
of parent organizations concerned with immunizations, representatives
of State or local health agencies, or public health organizations.
Individuals selected for appointment to the Committee can be invited to
serve terms with periods of up to four years.
Nominations should be typewritten. The following information should
be included in the package of material submitted for each individual
being nominated for consideration: (1) A letter of nomination that
clearly states the name and affiliation of the nominee, the basis for
the nomination (i.e., specific attributes which qualify the nominee for
service in this capacity), and a statement that the nominee is willing
to serve as a member of the Committee; (2) the nominator's name,
address, and daytime telephone number, and the home and/or work
address, telephone number, and e-mail address of the individual being
nominated; and (3) a current copy of the nominee's curriculum vitae.
Applications cannot be submitted by facsimile. The names of Federal
employees should not be submitted for consideration of appointment to
this Committee.
The Department makes every effort to ensure that the membership of
HHS Federal advisory committees is fairly balanced in terms of points
of view represented and the committee's function. Every effort is made
to ensure that a broad representation of geographic areas, gender,
ethnic and minority groups, and the disabled are given consideration
for membership on HHS Federal advisory committees. Appointment to this
committee shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
Dated: November 30, 2006.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. E6-20636 Filed 12-5-06; 8:45 am]
BILLING CODE 4150-44-P